ArticlePDF Available

The Hidden Potential of Herbal Remedies and Neutraceuticals in Canine and Feline Behavioural Disorders

Authors:

Abstract

Veterinary practitioners may encounter a wide variety of behaviorual problems such as aggresion, anxiety, compulsive behaviours, inappropriate elimination and cognitive dysfunction in daily practice. With the advance of scientific researches regarding usage of herbs and nutraceuticals in order to treat these behavioural problems, veterinarians and animal owners look for reliable sources to gain knowladge about that therapeutics. As elucidated by many published researches, neurotransmitters such as GABA, serotonin, dopamine and norepinephrine act in pathology of many psychiatric disorders and most of the modern drugs show their mechanism of action by regulating these neurochemicals. There is increasing evidence that herbal extracts and nutraceuticals act in a similiar way with the conventional therapeutics however, lots of conventional medicines have remarkable side effect unlike herbal and nutraceutical therapeutics. Despite the increasing number of studies, the mechanism of action of these therapeutics has not been fully elucidated. This review aims to introduce recent scientific knowledge on herbal and nutraceutical remedies, that may be alternative treatment models in dog and cat behavioural problems.
36
*Corresponding author: umut.burak.aan@gm ail.com
This work is licensed under a Creative Commons Attribution -NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non -commercial purposes from the material, as long as the author of the original work is cited properly.
Van Vet J, 2022, 33 (1) 36-41
Van Veterinary Journal
https://dergipark.org.tr/tr/pub/vanvetj
Cite this article as: Ağan UB, Hosseinpou r Raouf S, Uzun B, Meral Y (2022). The Hidden Potential of Herbal Remedies
and Neutraceuticals in Canine and Feline Behavioural D isorders. Van Vet J, 33(1), 36-41. DOI:
https://doi.org/10.36483/vanvetj.955081
ISSN: 2149-3359
Review
e-ISSN: 2149-8644
The Hidden Potential of Herbal Remedies and Neutraceuticals in Canine and Feline
Behavioural Disorders
Umut Burak AĞAN1, * Saba HOSSEINPOUR RAOUF1 Büşra UZUN1 Yücel MERAL1
1 Ondokuz Mayıs University, Faculty of Veterinary Medicine, Department of Internal Medicine, 55000, Samsun, Turkey
Received: 22.06.2021
Accepted: 10.10.2021
ABSTRACT
ÖZ
INTRODUCTION
Demand for etiology-based treatment options is increasing
parallel to the growing behavioural problems in dogs. A
recent study by Didehban et al. demonstrated that dog
behavioural problems are one of the leading reasons for
consulting a veterinarian and 86% of the dogs included in
the study had at least one behavioural problem (Didehban
et al. 2020). Veterinary practitioners may encounter a
wide variety of behavioural problems such as aggression,
anxiety, compulsive behaviours, inappropriate elimination
and cognitive dysfunction in daily practice. Every animal
presented with behavioural complaints need to be
assessed in terms of overall health and a detailed history
should be taken to determine whether the behaviour is
normal, abnormal or is it an underlying medical condition
(Seibert and Landsberg 2008).
In human medicine, patients that suffer from anxiety, tend
to seek alternative therapies due to adverse side effects of
medications and collective prejudices (Liu et al. 2017).
Similar tendency for alternative therapies and prejudice
[Umut Burak AĞAN et al.] Van Vet J, 2022, 33 (1) 36-41
37
for medical psychoactives are prevalent in dog owners.
The Perception of dog owners against psychoactive
medications and non-prescription alternative treatments
was investigated and a significant majority of attendants
remarked that they felt the highest comfort level with
herbal and nutritional supplements, compared to medical
options (van Haaften et al. 2020).
There is increasing evidence that herbal extracts can
reduce anxiety symptoms through the regulation of
neurotransmitters (Alex and Srivastava 2019). Anxiety and
stress have similar development and results in humans
and dogs regarding many aspects. Neurotransmitters such
as GABA, serotonin, dopamine and norepinephrine mainly
partake in the pathogenesis of anxiety disorders. GABA
modulating phytochemicals may be an alternative to
anxiolytic medications (Savage et al. 2018). Antidepressive
effects of some herbal remedies via monoamine Oxidase-A
enzyme (MAO) inhibition, are similar to the effects of
tricyclic antidepressants (Zhang 2004).
Although rare, problems related to drug interactions and
previous pathologies existing in animals should be
considered when using herbal medicines in veterinary
medicine. Quality, extraction method, concentration and
purity have vital importance for the reliability of herbal
remedies. Adverse effects due to remedies containing
environmental pollutants such as heavy metals and
mycotoxins also must be considered (Eritja 2014).
This review aims to introduce recent scientific knowledge
on herbal and nutraceutical remedies, that may be
alternative treatment models in dog and cat behavioural
problems.
Herbal Remedies
Souroubea spp.
S. sympetala has been used in folk medicine to treat
depression-like symptoms. Preclinical studies of souroubea
spp. have shown an anxiolytic effect on rodents. Betulinic
acid (BA) is one of the active metabolites of Souroubea
spp. and anxiolytic effect of the herb is mainly attributed to
BA. A commercial preperation which is composed of 55/45
mixture of Souroubea spp./ Plantus spp, which is equal to
1mg/kg BA for a 10kg dog has provided dose dependent
decrease of plasma cortisol levels and significant anxiolytic
effect on dogs (Liu et al. 2017). Chewable tablets consisting
of a mixture of souroubea and plantarus at a dose of 1
mg/kg were used in the thunderstorm noise-induced fear
and anxiety model of dogs, and their effectiveness in
reducing anxiety in dogs was evaluated. This blind,
placebo-controlled study showed that anxiety symptoms
and blood cortisol levels decreased in a dose-dependent
manner (Masic et al. 2021).
Canabis Sativa (Hemp)
Canabis sativa has been used by various cultures in
traditional medicine for ages. Canabis sativa contains
numerous physiologically active phytochemicals such as
tetrahydrocannabinol (THC), cannabinidiol (CBD),
cannabigerol (CBG), and cannabichromene (CBC) (Lipnik-
Štangelj & Razinger, 2020). THC binds with the
cannabinoid 1 (CB1) receptors in the brain, resulting with
euphoria, so it is the undesired metabolite. According to
EU regulations, THC content cannot exceed 0.2% in
veterinary products and hemp products are widely
prescribed in USA and EU. Mechanism of action of CBD is
not yet to be understood completely, but it is known that
CBD modulates CB-1 receptor function, GABA, dopamine
levels and serotonin function. Several human studies have
shown its effectiveness on anxiety and psychotic
symptoms and it can be considered as a safe molecule
(Ayati et al. 2020). Although it is used empirically, many
veterinarians successfully use cannabis derivatives in
many pathologies such as pain management, mood
disorders, anxiety, depression, and seizures in dogs and
cats (della Rocca and Di Salvo 2020). In a study on shelter
dogs, effects of CBD on stress related behaviours were
investigated and the results, although not statistically
significant, demonstrated decrease in aggressive
behaviours toward humans (Corsetti et al. 2021).
Withania Somnifera (Ashwaganha)
Withania somnifera, also known as Indian Ginseng has
been studied for its neuroprotective, adaptogenic,
anxiolytic and antidepressant effects. A randomized
clinical trial has demonstrated the effectiveness of
withania root extract on depression, anxiety and social
dysfunction (Ayati et al. 2020). Glycowithanolides (WSG),
extracted from the root of Withania somnifera has been
used as an anxiolytic by Indians. It is thought Withania
somnifera exhibits an effect by inhibiting protein oxidation
and lipid peroxidation (Zhang 2004). Rodents treated with
Withania presented reduced anxiety and this reduction
was found similir to the effects of benzodiazepines (Alex
and Srivastava 2019).
Pasiflora incarnata (Passion Flower)
Pasiflora incarnata, also known as Passion Flower is a
perennial herb. Studies indicate that passion flower has
effects on anxiety, reactivity, insomnia and depression-like
behaviours comparable to benzodiazepines (Fonseca et al.
2020). Pasiflora is one of the herbal remedies that can be
used to reduce stress in animals and there is no report
about adverse effects, such as memory loss and collapse of
psychometric functions relating to the adminastration of
passion flower (Janda et al. 2020). A mixture containing
dry extracts of Crataegus oxyacantha, Passiflora incarnata,
and Valeriana officinalis was studied toxicologically on
dogs, mice, and rats, and Ld50 dose was indicated as 5g/kg
and possibly more, also acute and chronic toxicity trials
were conducted for 180 days and no signs of toxicity were
observed at the end of the study, even with high doses and
long-term use (Tabach et al. 2009). Due to the low toxicity
profile and benzodiazepine like effects of the herb, Passion
Flower could be a first-line therapeutic option for mild to
moderate anxieties in dogs.
Hypericum Perforatum (St John's wort)
Hypericum perforatum, one of the most studied herbs due
to its antidepressant effects and the herb has many active
metabolites. Its possible mechanism of action is attributed
to inhibition of monoaminergic reuptake and inhibition of
Monoamine Oxidase A (MAO-A) and MAO-B activity
(Zhang, 2004). Numerous clinical studies and animal
experiments demonstrated that H.perforatum exerts its
effect through a mechanism similar to tricyclic
antidepressants or serotonin reuptake inhibitors (Alex and
Srivastava 2019). In a striking study comparing hypericin
(one of the active ingredients of Hypericum perforatum,
0.05 mg/kg) and fluoxetine (1 mg/kg) in 18 dogs with tail
chasing behaviour, hypericin was found to have superior
clinical effects compared to fluoxetine (Mosallanejad et al.
2015). Data in human medicine has demonstrated that
hypericum perforatum may lead to drug interaction when
used concurrently with cyclosporine and many other
drugs due to common enzymatic metabolism. Furthermore
it could lead to serotonin syndrome when used with SSRIs
and side effects such as nausea, photosensitivity, and rash,
although not frequent were observed (Ng et al. 2017).
[Complementary Treatments for Behavioural Disorders] Van Vet J, 2022, 33 (1) 36-41
38
Camelia Sinensis (Green Tea)
Green tea has been used by traditional medical
applications and it has various pharmacological and
physiological functions. It has been well documented that,
L-theanine, that is a main constituent of green tea has
stress and anxiety reducing, neuroprotective and
antioxidant effects (Saeed et al. 2017). A study has
compared the effects of a nutraceutical (green tea extract,
L-tryptophane) and control diet, on stress and
neuroendocrine parameters of dogs. Results of the study
revealed that plasma serotonin, dopamine and beta
endorphin levels of dogs in the study group were
significantly higher than the control group and plasma
noradrenaline and cortisol levels were significantly lower
in the study group (Sechi et al. 2017).
Melissa Oficinalis (Lemon Balm)
Melissa officinalis has been used historically due to it’s
anxiolytic effects. Studies performed with aqueous extract
of the herb on mice, has demonstrated increased
explanatory activity and sedation (Zhang 2004). In another
study performed on mouses, Melissa officinalis extract
administration has shown dose dependent decrease of
serum corticosterone levels, additionally increased GABA
levels in mouse dentate gyrus (Yoo et al. 2011).
Matricaria Recutita (Chamomile)
Matricaria is also commonly called as German Chamomile
and it is a very popular herb for various diseases. It is
known that among the other effects, chamomile has
anxiolytic, anti-stress and anti-depressive effects. In
according to the results of an animal study, chamomile
extract has alleviated the anxiety and depression related to
the scopolamine injection (Ioniță et al. 2019).
Centella Asiatica (Gotu Kola)
Centella Asiatica has been used by Indians due to its
beneficial effects on cognition and anxiety. Extracts of the
herb have shown GABA receptor modulating activity,
neuroprotective features and memory ehancement effect
(Ceremuga et al. 2015). A study had investigated the
effectiveness of Gotu kola extract for ameliorating vascular
cognitive impairment (VCI) after stroke and compared it’s
effectiveness against folic acid. Gotu kola has been found
superior to folic acid in terms of memory improving and as
affective as folic acid for in improvement of post-stroke
VCI (Farhana et al. 2016). As suggested by Wynn and
Fougère (2007), 25%-40% ethanolic extract of gotu kola
may be efficient for cognitive impairment of dogs and cats
in a dose range of 0.4-1.5 ml per 10 kg.
Bacopa Monniera (Bacopa)
As an Ayurvedic plant Bacopa has been used for centuries.
Several studies have investigated antidepressant and
anxiolytic activity of the plant and show that Bacopa has
anxiolytic activity without adverse effects like amnesia as
in benzodiazepines and has significant antidepressant
effects (Gohil and Patel 2010). It is known that Bacopa has
a norepinephrine decreasing effect and increasing 5-
hydroxytryptamine in brain zones such as hippocampus
and amygdala (Russo and Borrelli 2005). In a rat study,
Bacopa extract orally at different durations of 20 to 80
mg/kg has been shown to improve memory and learning
(Vollala et al. 2010).
Valeriana Officinalis (Valerian)
Valerian has been used in traditional and ayurvedic
medicine due to a relaxant and sleep-promoting effects.
Nearly 150-200 chemical metabolites have been found in
valerian. Some of these constituents have been found to
have potantial therapeutic effects in alzhaimer, parkinson
and epilepsy diseases. Root extract of valerian has shown
cognitive enhancing and corticosterone reducing effects, in
aged mice (Nandhini et al. 2018). In a study conducted on
cats, responses to the use of valerian root for
environmental enrichment as an olfactory stimulant were
evaluated and 47% of cats responded. Results suggest that
usage of valerian root may improve the quality of life in
cats (Bol et al. 2017). In another study conducted on
shelter dogs, the effect of olfactory stimuli on behavior was
evaluated and it was shown that valerian and other
olfactory stimulants significantly affect behavior, reduce
vocalization and movement. Reduced vocalization and
movement may be associated with reduced stress
provided by the use of olfactory stimulants (Binks et al.
2018).
Lavandula Officinalis (Lavander)
L.officinalis has antidepressive and sedative usage besides
it’s various medical advantages. A study which is
conducted on rats showed that extract of aerial parts of
Lavandula possess antidepressive-like effects, anxiety and
scopolamine induced memory impairment reducing effects
(Rahmati et al. 2017). A study conducted on 16 cats has
assessed the aromatherapeutic potential of lavender oil in
reducing anxiety in cats. The study group received
lavender oil by inhalation for 30 minutes. As the result, a
statistically significant decrease in stress and anxiety-
related behaviors was observed in the study group
(Goodwin and Reynolds 2018). Due to its non-invasiveness
and promising results, lavender oil can be used in cats as
an additional treatment option in anxiety management.
Ginkgo Biloba
Ginkgo biloba is frequently used by humans to ameliorate
age-related cognitive impairments. It is one of the most
studied herbs due to its neurological effects. It is known
that ginkgo has various effects on the brain including
enhancement of neuronal plasticity, memory improving
and protecting against ischemic neuronal death (Singh et
al. 2019). A study performed on aged beagle dogs has
shown that a nutraceutical preparation composed of
phosphatidylserine, Ginkgo biloba, Vitamin E and
pyridoxine enhanced the short-term memory performance
of dogs. Along with the benefits of other substances, the
study indicated that Ginkgo may possess the promote
short-term retention of spatial memory thereby enhancing
cognitive functions in animals (Araujo et al. 2008). In
another study conducted on 46 dogs, a commercial
preparation which is containing phosphatidylserine and
Ginkgo biloba standardized extract has evaluated for its
effectiveness and tolerability. At the end of the 3 months
treatment 66% of the subjects responded to treatment
with improved signs in terms of the general activity,
sleep/awake cycle, house soiling, disorientation and social
interactions (Cane et al. 2005).
Other Herbs
Piper methysticum is a well-known herb due to it’s
anxiolytic effect. The main active constituent of the herb
has shown the various mechanism of action such as
increase of GABA-A receptor functioning, inhibition of
excitatory neurotransmission and inhibition of
norepinephrine uptake (Zhang 2004).
Ziziphus jujube has been used in Traditional Chinese
Medicine (TCM) and laboratory studies have revealed that
extract of the herb act as an anxiolytic at lower doses and
sedative at higher doses (Peng et al. 2000).
[Umut Burak AĞAN et al.] Van Vet J, 2022, 33 (1) 36-41
39
Extract of the Apocynum venetum has an antidepressant
effect and it is thought that mechanism of action of the
herb is related to its effect on the central monoaminergic
system, as in conventional antidepressants(Meizhu et al.
2014).
Constituent of Atecha catechu's nut has shown significant
inhibitory effect on GABA uptake and in-vitro studies
carried out with the phenolic compounds of the herb had
stimulated the catecholamine release (Zhang 2004).
Table 1. Recommended herbals and nutraceuticals for behavioural problems of dogs and cats.
Herbals and
Nutraceuticals
Effects on Behavioural Conditions
Potential Indications
References
Pasiflora
incarnata
Stress reducing and benzodiazepin-like
effects
Canine and Feline Anxiety
Insomnia
Depressive Behaviours
(Janda et al. 2020)
(Fonseca et al. 2020)
Hypericum
perforatum
Inhibition of monoaminergic reuptake
and inhibition of (MAO)-A and MAO-B
activity
Depressive Behaviours
Anxiety
Tail-Chasing
(Zhang 2004)
(Alex and Srivastava 2019)
(Mosallanejad et al. 2015)
(Ng et al. 2017)
Matricaria
recutita
Anxiolytic, Antidepressive and Anti-
stress
Depressive Behaviours
Anxiety
(Ioniță et al. 2019).
Withania
somnifera
Anxiolytic, Adaptogen and
Antidepressive
Depressive Behaviours
Anxiety
(Alex and Srivastava 2019)
(Ayati et al. 2020)
(Zhang 2004)
Canabis Sativa
(CBD) l
Alteration of CB-1 receptor function,
GABA and dopamine levels, and
serotonin function
Depressive Behaviours
Canine Aggression
(della Rocca and Di Salvo
2020)
Ayati et al. 2020)
(Corsetti et al. 2021)
Camelia Sinensis
Neuroprotective, stress and anxiety
reducing effects
Anxiety
(Saeed et al. 2017)
(Sechi et al. 2017)
Melissa officinalis
Decrease serum corticosterone levels
and increase dentate gyrus GABA levels
Cognitive dysfunction
Anxiety
(Zhang 2004)
(Yoo et al. 2011)
Gotu Kola
GABA receptor modulation
Memory enhancement and
Neuroprotective
Cognitive dysfunction
Anxiety
(Ceremuga et al. 2015)
(Farhana et al. 2016)
(Wynn and Fougère 2007)
Bacopa monniera
Increase brain serotonin and decrease
brain norepinephrine
Anxiolytic and Antidepressive
Cognitive dysfunction
Depressive behaviours
Anxiety
(Gohil and Patel 2010)
(Russo and Borrelli 2005)
(Vollala et al. 2010)
Lavandula
officinalis
Antidepressive
Anxiety reducing
Depressive Behaviours
Anxiety
(Rahmati et al. 2017)
(Goodwin and Reynolds
2018)
Valeriana
officinalis
Relaxant, Sleep promoting, Sedative
Insomnia
Feline Hyperesthesia
Stress
(Nandhini et al. 2018)
(Bol et al. 2017)
(Binks et al. 2018)
Ginkgo biloba
Neuroprotective, Memory Improving,
Cognitive dysfunction
(Singh et al. 2019)
(Araujo et al. 2008)
(Cane et al. 2005)
Bovine Milk
Protein derivates
Stress reducing
Anxiolytic
Anxiety
Depressive Behaviours
(Orlando 2018)
(Beulens et al. 2004)
(Beata et al. 2007)
Apoaequorin
Neuroprotective effect by intracellular
calcium regulation
Cognitive Dysfunction
(Milgram et al. 2015)
(Orlando 2018)
MCTs
Support brain energy metabolism
Cognitive Dysfunction
Neuroprotection
(Pan et al. 2010)
(Orlando 2018)
Omega-3
Neuroprotective and neuronal
development
Cognitive Dysfunction
(Orlando 2018)
(Kaur et al. 2020)
SAMe
Cellular metabolism regulation, Cell
membrane stability
Cognitive Dysfunction
(Orlando 2018)
Tryptophan
Precursor serotonin synthesis
Phobias
Aggression
Anxiety
(Orlando 2018)
Nutraceuticals
Bovine milk protein derivates include alpha casozepine
and alpha-lactalbumin, these compounds greatly reduced
anxiety signs and plasma cortisol levels in dogs besides
reduced social anxiety in cats (Orlando 2018). In a study,
rats fed with alpha-lactalbumin enriched diets have shown
increased serotonin levels and increased activity levels. In
the same study alpha lactalbumin has found superior to
casein in terms of profitable effects on mood (Orosco et al.
2004).
[Complementary Treatments for Behavioural Disorders] Van Vet J, 2022, 33 (1) 36-41
40
It is known that a high ratio of tryptophan to other large
neutral amino acids (LNAAs) in the diet is important for
serotonin synthesis. Alpha-lactalbumin enriched diets
increaseserum tryptophan to LNAAs ratio (Beulens et al.
2004). Numerous commercial diets that include bovine
milk protein derivates have already been available in the
market. A study that compares the effectiveness of alpha-
casozepine and selegiline on anxiety disorders in dogs
have shown that alpha-casozepine is equivalently effective
as selegiline and during the study no adverse effects were
recorded regarding the use of alpha-casozepine (Beata et
al. 2007).
Apoaequorin is a protein derived from jellyfish and it has a
better improvement effect on cognitive functions in aged
beagle dogs compared to selegiline (Orlando 2018).
Apoaequorin has calcium buffering properties and thus
protects against pathologies related to calcium
dysregulation and excitotoxicity. In a placebo-controlled
study, 23 aged beagle dogs have treated with apoaequorin
and the study group has shown enhanced cognitive results.
In a second study, 10 mg apoaequorin administration has
been shown as effective as selegiline treatment for canine
cognitive dysfunction (Milgram et al. 2015).
Medium-chain triglycerides (MCT), it is known that in aged
dogs brain glucose metabolism is altered. MCTs act as a
second energy source in the form of ketones to support
brain energy metabolism when given as a food additive.
Beta-hydroxybutyrate, a ketone body, levels were
found significantly higher in the MCT supplemented dogs
(Pan et al. 2010). In a study performed on aged beagle
dogs, feeding with a proportion of 5.5% MCT added diet
improved cognitive test scores. In another study
performed on owned dogs, 6.5% MCT containing diet has
shown significant amelioration of the clinical signs of
cognitive dysfunction in one month (Orlando 2018).
Omega-3 fatty acids are polyunsaturated fatty acids that
are essential for the canine diet. They have beneficial
properties for various conditions of dogs such as epilepsy,
cardiovascular diseases, and dermatlogical problems
(Kaur et al. 2020). Docosahexaenoic acid (DHA) and
eicosapentaenoic acid (EPA) are omega-3 fatty acids
usually derived from fish oil. It is known that DHA play a
crucial role in the neurological and cognitive development
of puppies (Orlando 2018).
SAMe (S-Adenosylmethionine) plays vital roles in cellular
metabolism, cell membrane stability and neurotransmitter
functions. In a study, dogs and cats with cognitive
dysfunction syndrome treated with SAMe have shown
improvement in cognitive abilities (Orlando 2018). In cats
with mild cognitive dysfunction syndrome, the
administration of SAMe has shown an improvement in
cognitive abilities (Sordo and Gunn-Moore 2021).
Tryptophan is a dietary amino acid used in the production
of serotonin. In addition to the amount in the diet, the ratio
to other large neutral amino acids is also important.
Owner-directed aggression score has been found higher in
dogs fed with high protein diets and in fearful dogs,
increased levels of plasma tryptophan metabolites and
decreased levels of tryptophan have been found (Orlando
2018).
Vitamin B-6, Vitamin E, resveratrol, alpha-tocopherol, and
L-carnitin are other substances that might be used to
ameliorate cognitive dysfunction in dogs and cats (Sordo
and Gunn-Moore 2021).
CONCLUSION
Herbal and nutraceutical remedies have many advantages
in veterinary medicine such as low cost, availability and
positive owner attitude, etc. Alas, people generally fixed at
the opinion that, herbal remedies have no side effects. This
is a crucial fault, as many herbs have various and vital side
effects. The dilemma in herbal and nutraceutical remedies
can be solved by choosing the right extraction, suitable
dose and indication. Still there are promising therapeutic
potentials in these remedies with the advances in
phytochemical researches, that must be considered in
veterinary medicine.
CONFLICTS OF INTEREST
The authors report no conflicts of interest.
ACKNOWLEDGMENT
We would like to thank Prof. Dr. Duygu Dalgin, a faculty
member of Ondokuz Mayis University, Faculty of
Veterinary Medicine, Department of Internal Medicine, for
her support at every step of this study.
AUTHOR CONTRIBUTIONS
Idea / Concept: UBA
Supervision / Consultancy: YM
Data Collection and / or Processing: UBA
Analysis and / or Interpretation: SHR, BU
Writing the Article: UBA
Critical Review: SHR, BU
REFERENCES
Alex A, Srivastava A (2019). Nutraceuticals for Calming and Stress. Gupta
RC, Srivastava A, Lall R (Ed). Nutraceuticals in Veterinary Medicine,
417-425, Springer, Switzerland.
Araujo JA, Landsberg GM, Mil gram NW, Miolo A (2008). Improvement of
short-term memory performance in aged beagles by a nutraceutical
supplement containing phosphatidylserine, Ginkgo biloba, vitamin E,
and pyridoxine. Can Vet J, 49 (4), 379-385.
Ayati Z, Sarris J, Cha ng D, Emami SA, Rahimi R (2020). Herbal medicines
and phytochemicals for obsessivecompulsive disorder. Phytother Res,
34 (8), 1889-1901.
Beata C, Beaumont -graff E, Diaz C et al. (2007). Effects of alpha-
casozepine (Zylkene) versus selegiline hydrochlorid e (Selgian, Anipryl)
on anxiety disorders in dogs. J Vet Behav, 2 (5), 175-183.
Beulens JWJ, Bindels JG, De GraafC, Alles MS, Wouters-Wesseling W
(2004). Alpha-lactalbumin combi ned with a regular diet increases
plasma Trp-LNAA ratio. Physiol Behav, 81 (4), 585-593.
Binks J, Taylor S, Wills A, Montrose VT (2018). The behaviour al effects of
olfactory stimulation on dogs at a rescue shelter. Appl Anim Behav Sci,
202, 69-76.
Bol S, Caspers J, Buckingham L et al. (2017). Responsiveness of cats
(Felidae) to silver vine (Actinidia poly gama), Tatarian honeysuckle
(Lonicera tatarica), valerian (Valeriana officinalis) and catnip (Nepeta
cataria). BMC Vet Res, 13 (1), 1-15.
Cane NEL, P ilota S, Colangeli R et al. (2005). Di Un Nutraceutico
Neuroprotettivo Contenente Fosfatidilserina E Ginkgo Biloba Sui Segni
Clinici Di Invecchiamento Cerebrale. 2005(October), 13-18.
Ceremuga TE, Valdivieso D, Kenner C et al. (2015). Evaluation of the
anxiolytic and antidepressant effects of asiatic acid, a compound fro m
Gotu kola or Centella asiatica, in the male Sprague Dawley rat. AANA J,
83 (2), 91-98.
Corsetti S, Borruso S, Malandrucco L et al. (2021). Cannabis sativa L.
may reduce aggressive behaviour towards humans in shelter dogs. Sci
Rep, 11 (1), 1-10.
della Rocca G, Di Salvo A ( 2020). Hemp in Veterinary Medicine: From
Feed to Drug. Front Vet Sci, 7 (387), 1-11.
Didehban N, Pourmahdi Borujeni M, Avizeh, R, Mosallanejad B (2020).
Problematic behaviors in companion dogs: A survey of their
prevalence and associated factors. J Vet Behav, 39, 6-13.
[Umut Burak AĞAN et al.] Van Vet J, 2022, 33 (1) 36-41
41
Eritja R (2014). Natural Product Communications: Preface. Nat Prod
Commun, 9 (8).
Farhana KM, Malueka RG, Wibowo S, Gofir A (2016). Effectiveness of
Gotu Kola Extract 750 mg and 1000 mg Compared with Folic Acid 3 mg
in Improving Vascular Cognitive Impairment after Stroke. Evid-based
Complement Altern, 2016, 2795915.
Fonseca LRd, Rodrigues R de A, Ramos A de S et al. (2020). Herbal
Medicinal Products from Passiflora for Anxiety: An U nexploited
Potential. Sci World J, 2020, 6598434.
Gohil KJ, Patel JJ (2010). A review on Bacopa monniera: Current research
and future prospects. Int J Green Pharm, 4 (1), 19.
Goodwin S, Reynolds H (2018). Can aromatherapy be used to reduc e
anxiety in hospitalised felines. The Veterinary Nurse, 9 (3), 167-171.
Ioniță R, Postu PA, Cioancă O et al. (2019). Anxiolytic and antidepressant
effects of matricaria chamomilla hydroalcoholic extract in a rat model
of scopolamine. Farmacia, 67 (1), 68-72.
Janda K, Wojtkowska K, Jaku bczyk K, Antoniewicz J, Skonieczna-
żydecka K (2020). Passiflora incarnata in neuropsychiatric disorders-
a systematic review. Nutrients, 12 (12), 1-17.
Kaur H, Singla A, Singh S, Shilwant S, Kaur R (2020). Role of Omega-3
Fatty Acids in Canine Health: A Review. Int j curr microbiol, 9 (3), 2283-
2293.
Lipnik-Štangelj M, Razinger B (2020). A regulatory take o n cannabis and
cannabinoids for medicinal use in the European Union. Arhiv Za
Higijenu Rada i Toksikologiju, 71 (1), 12-18.
Liu R, Ahmed F, Cayer C et al. (2017). New Botanical Anxiolytics for Use
in Companion Animals and Humans. AAPS J, 19 (6), 1626-1631.
Masic A, Landsberg G, Milgram B et al. (2021). Efficacy of Souroubea-
Platanus Dietary Supplement Containing Triterpenes in Beagle Dogs
Using a Thunderstorm Noise-Induced Model of Fear and Anxiety.
Molecules, 26 (7), 2049.
Meizhu Z, Yuqiu L, Dongfang S, Chunming L, Jimin Z (2014).
Antidepressant-like effects of flavonoids extracted from Apocynum
venetum leaves in mice: the involvement of monoaminergic system in
mice. Afr J Pharmacy Pharmacol, 8 (29), 765-774.
Milgram NW, Landsberg G, Merrick D, Underwood MY (2015). A novel
mechanism for cognitive enhancement in aged dogs with the use of a
calcium-buffering protein. J Vet Behav, 10 (3), 217-222.
Mosallanejad B, Najafzadeh Varzi H, Avizeh R, Pourmahdi M, Khalili F
(2015). Comparative evaluation between hy pericin (hypiran) and
fluoxetine in treatment of companion dogs with tail chasing. Vet Res
Forum, 6 (2), 167-172.
Nandhini S, Narayanan KB, Ilango K (2018). Valeriana Officinalis: a
Review of Its Traditional Uses, Phytochemistry and Pharmacology. J
Pharm Clin Res, 11 (1), 36.
Ng QX, Venkatanarayanan N, Ho CYX (2017). Clinical use of Hypericum
perforatum (St John’s wort) in depression: A meta-analysis. J Affect
Disord, 210, 211221.
Orlando JM (2018). Behavioral Nutraceuticals and Diets. Vet Clin North Am
Small Anim Pract, 48 (3), 473-495.
Orosco M, Rouch C, Beslot F et al. (2004). Alpha-lactalbumin-enriched
diets enhance serotonin release and induce anxiolytic and rewarding
effects in the rat. Behav Brain Res, 148 (12), 1-10.
Pan Y, Larson B, Araujo JA et al. (2010). Dietary supplementation with
medium-chain TAG has long-lasting cognition-enhancing effects in
aged dogs. Br J Nutr, 103 (12), 1746-1754.
Peng WH, Hsieh MT, Lee YS, Lin YC, Liao J (2000). Anxiolytic effect of
seed of Ziziphus jujuba in mouse models of anxiety. J Ethnopharmacol,
72 (3), 435-441.
Rahmati B, Kiasalari Z, Roghani M, Khalili M, Ansari F (2017).
Antidepressant and anxiolytic activity of Lavandula officinalis aerial
parts hydroalcoholic extract in scopolamine-treated rats. Pharm Biol,
55 (1), 958-965.
Russo A, Borrelli F (2005). Bacopa monniera, a reputed nootropic plant:
An overview. Phytomedicine, 12 (4), 305-317.
Saeed M, Naveed M, Arif M et al. (2017). Green tea (Camellia sinensis)
and L-theanine: Medicinal values and beneficial applications in
humansA c omprehensive review. Biomed Pharmacother, 95
(September), 1260-1275.
Savage K, Firth J, Stough C, Sarris J (2018). GABA-modulating
phytomedicines for a nxiety: A syste matic review of preclinical a nd
clinical evidence. Phytother Res, 32 (1), 3-18.
Sechi S, Fiore F, Cocco R et al. (2017). Effects in dogs with behavioural
disorders of a commercial nutraceutical diet on stress and
neuroendocrine parameters. Vet Rec, 180 (1), 18.
Seibert LM, Landsberg GM (2008). Diagnosis and Manageme nt of Patients
Presenting with Behavior Problems. V et Clin North Am Small Anim
Pract, 38 (5), 937-950.
Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G (2019).
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract
Against A D and Other N eurological Disorders. Neurother, 16 (3), 666-
674.
Sordo L, Gunn-Moore DA (2021). Cognitiv e Dysfunction in Cats: Update
on Neuropathological and Behavioural Changes Plus Clinical
Management. Vet Rec, 188 (1), 30-41.
Tabach R, Rodrigues E, Carlini EA (2009). Preclinical toxicological
assessment of a phytotherapeutic product CPV (based on dry extracts
of Crataegus oxyacantha L., Passiflora inca rnata L., and Valeriana
officinalis L.). Phytother Res, 23, 33-40.
Van Haaften KA, Grigg EK, Kolus C, Hart L, Kogan LR (2020). A survey of
dog owners’ perceptions on the use of psychoactive medications and
alternatives for the treatment of canine behavior problems. J Vet Behav,
35, 27-33.
Vollala VR, Upadhya S, Nayak S (2010). Effect of Bacopa monniera Linn.
(brahmi) extract on learning and memory in rats: A behavioral study. J
Vet Behav, 5 (2), 69-74.
Wynn SG, Fougère B (2007). Veterinary herbal medicine. Elsevier Health
Sciences, Missouri.
Yoo DY, Choi JH, Kim W et al. (2011). Effects of Melissa officinalis L.
(Lemon Balm) extract on neurogenesis associated with serum
corticosterone a nd GABA in the mouse dentate gyrus. Neurochem Res,
36 (2), 250-257.
Zhang ZJ (2004). Therapeutic effects of herbal extracts and constituents in
animal models of psychiatric disorders. Life Sci, 75 (14), 1659-1699.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
A novel botanical dietary supplement, formulated as a chewable tablet containing a defined mixture of Souroubea spp. vine and Platanus spp. Bark, was tested as a canine anxiolytic for thunderstorm noise-induced stress (noise aversion). The tablet contained five highly stable triterpenes and delivered 10 mg of the active ingredient betulinic acid (BA) for an intended 1 mg/kg dose in a 10 kg dog. BA in tablets was stable for 30 months in storage at 23 °C. Efficacy of the tablets in reducing anxiety in dogs was assessed in a blinded, placebo-controlled study by recording changes in blood cortisol levels and measures of behavioral activity in response to recorded intermittent thunder. Sixty beagles were assigned into groups receiving: placebo, 0.5×, 1×, 2×, and 4× dose, or the positive control (diazepam), for five days. Reduction in anxiety measures was partially dose-dependent and the 1× dose was effective in reducing inactivity time (p = 0.0111) or increased activity time (p = 0.0299) compared with placebo, indicating a decrease in anxiety response. Cortisol measures also showed a dose-dependent reduction in cortisol in dogs treated with the test tablet.
Article
Full-text available
Among the phytocomplex components of Cannabis sativa L . , cannabidiol (CBD) has a recognised therapeutic effect on chronic pain. Little is known about the veterinary use of CBD in dogs. Even less is known on the effects of CBD on dog behaviour, especially in shelters. The purpose of this study was to determine if CBD affects stress related behaviour in shelter dogs. The sample consisted of 24 dogs divided into two groups that were created by assigning the dogs alternately: 12 dogs were assigned to the treatment group and 12 to the control group. Extra virgin olive oil, titrated to 5% in CBD was given to treated group; the placebo consisted of olive oil only, dispensed daily for 45 days. Behavioural data were collected using the ‘focal animal’ sampling method with ‘all occurrences’ and ‘1/0’ methods for 3 h: before (T 0 ), after 15 days (T 1 ), after 45 days of treatment (T 2 ) and after 15 days from the end of the treatment (T 3 ). Treated dogs showed reduced aggressive behaviour toward humans following the treatment (Friedman Test: χ ² = 13.300; df = 3; N = 12; p = .004; adj. sig. p = 0.027), but the difference in the decrease of aggressive behaviour between the two groups was not significant (Mann–Whitney U test, T 2 –T 0 : Z = − 1.81; N = 24; p = 0.078). Other behaviours indicative of stress, such as displacing activities and stereotypes, did not decrease. Despite some non-significant results, our findings suggest that it is worth doing more research to further investigate the effect of CBD on dog behaviour; this would be certainly valuable because the potential for improving the welfare of dogs in shelters is priceless.
Article
Full-text available
Cognitive dysfunction syndrome (CDS) is an established condition in cats that shares many similarities with human Alzheimer's disease (AD), where cognitive decline ultimately results in dementia. Cats with CDS display behavioural abnormalities, including excessive Vocalisation, altered Interaction with owners (increased affection/attention), altered Sleep‐wake cycles, House‐soiling, Disorientation (spatial and/or temporal), alterations in Activity, Anxiety, and/or Learning/memory deficits (i.e., VISHDAAL). These cats develop neuropathologies, such as accumulation of β‐amyloid and hyperphosphorylated tau deposits. Because of its similarities to those in the brains of people with cognitive impairment and AD, the domestic cat could be a natural model for human dementia studies. It is important to diagnose CDS promptly in cats, ruling out other causes for these behavioural changes, to provide effective management. Interventions include environmental enrichment (e.g., easy access to key resources, calming pheromones), dietary supplementations (e.g., Senilife, Aktivait for cats, SAMe), specific diets (e.g., containing antioxidants, medium‐chain triglycerides) and, potentially, medication (e.g., selegiline or propentofylline). This article reviews the literature about CDS in cats, its causes, neuropathology, clinical signs, diagnosis and potential management options. By doing so, it furthers our understanding of this condition and allows improved health, welfare and quality of life of affected cats.
Article
Full-text available
Background: Stress is a natural response of the body, induced by factors of a physical (hunger, thirst, and infection) and/or psychological (perceived threat, anxiety, or concern) nature. Chronic, long-term stress may cause problems with sleep, concentration, and memory, as well as affective disorders. The passionflower (Passiflora incarnata) is a perennial plant with documented therapeutic properties. The literature data suggest that the passionflower itself, as well as its preparations, helps reduce stress and can therefore be helpful in the treatment of insomnia, anxiety, and depression. The objective of this systematic review was to evaluate Passiflora incarnata in terms of its neuropsychiatric effects. Methods: The scientific databases PubMed, ClinTrials.gov, and Embase were searched up to 22 October 2019. The search identified randomized clinical trials describing the effects of Passiflora incarnata in neuropsychiatric disorders. Results: The systematic review included nine clinical trials. The duration of the studies included in the analysis varied widely, from one day up to 30 days. Study participants were no less than 18 years old. In each of the papers, the effects of passionflower were measured by using a number of different tests and scales. The majority of studies reported reduced anxiety levels following the administration of Passiflora incarnata preparations, with the effect less evident in people with mild anxiety symptoms. No adverse effects, including memory loss or collapse of psychometric functions, were observed. Conclusion: Passiflora incarnata may be helpful in treating some symptoms in neuropsychiatric patients.
Article
Full-text available
Hemp (Cannabis sativa) is an angiosperm plant belonging to the Cannabaceae family. Its cultivation dates back to centuries. It has always been cultivated due to the possibility of exploiting almost all the parts of the plant: paper, fabrics, ropes, bio-compounds with excellent insulating capacity, fuel, biodegradable plastic, antibacterial detergents, and food products, such as flour, oils, seeds, herbal teas, and beer, are indeed obtained from hemp. Hemp flowers have also always been used for their curative effects, as well as for recreational purposes due to their psychotropic effects. Cannabis contains almost 500 chemical compounds, such as phytocannabinoids, terpenes, flavonoids, amino acids, fatty acids, vitamins, and macro-, and micro-elements, among others. When utilized as a food source, hemp shows excellent nutritional and health-promoting (nutraceutical) properties, mainly due to the high content in polyunsaturated fatty acids (especially those belonging to the ω-3 series), as well as in phenolic compounds, which seem effective in the prevention of common diseases such as gastrointestinal disorders, neurodegenerative diseases, cancer, and others. Moreover, hemp oil and other oils (i.e., olive oil and medium-chain triglyceride–MCT–oil) enriched in CBD, as well as extracts from hemp dried flowers (Cannabis extracts), are authorized in some countries for therapeutic purposes as a second-choice approach (when conventional therapies have failed) for a certain number of clinical conditions such as pain and inflammation, epilepsy, anxiety disorders, nausea, emesis, and anorexia, among others. The present review will synthetize the beneficial properties of hemp and hemp derivatives in animal nutrition and therapeutics.
Article
Full-text available
Herbal medicines containing Passiflora species have been widely used to treat anxiety since ancient times. The species Passiflora incarnata L. is included in many Pharmacopoeias, and it is the most used species in food, cosmetic, and pharmaceutical industries. However, there are around 600 species of the genus Passiflora and probably other species that can be used safely. Thus, this article was based on a search into the uses of the main species of the genus Passiflora with anxiolytic activity and its main secondary metabolites and some pharmacological studies, patents, and registered products containing Passiflora. Furthermore, the Brazilian Regulatory Health Agency Datavisa, Medicines and Healthcare Products Regulatory Agency of the United Kingdom, and the European Medicines Agency websites were consulted. The results showed that Passiflora species have health benefits but clinical trials are still scarce. The complexity of Passiflora extracts creates challenges for the development of herbal medicines. P. incarnata is the most studied species of the genus and the most used in natural anxiolytic herbal medicine formulations. However, there are hundreds of Passiflora species potentially useful for medicinal and nutraceutical purposes that are still little explored.
Article
Full-text available
The discovery of the endocannabinoid system has raised public interest in the medicinal use of cannabis, phytocannabinoids, and synthetic cannabinoids, which has always been closely regulated due to their psychotropic effects and potential abuse. The review takes a quick look at the current legal framework in the European Union, which regulates cannabis use and cultivation for medicinal purposes in line with the United Nations Conventions on the production, trade, and use of cannabis, phytocannabinoids, and synthetic cannabinoids. And while the EU legislation precisely defines requirements and marketing authorisation procedures for medicinal products for all EU member states, there is no common regulatory framework for magistral and officinal preparations containing cannabinoids, as they are exempt from marketing authorisation. Instead, their regulation is left to each member state, and it is quite uneven at this point, mainly due to cultural and historical differences between the countries, leading to different access to non-authorised medicinal products. Therefore, to meet great public interest, harmonised approaches on cannabinoid-containing products without marketing authorisation would be welcome to level the playing field in the EU.
Article
Canine problematic behaviors are one of the most prevalent reasons given for referrals to small animal hospitals worldwide. Thus, the aim of the present study was to investigate the prevalence and possible variables related to 13 common problematic behaviors in 401 companion dogs referred to the Veterinary Hospital of Shahid Chamran University of Ahvaz, Iran. The results showed that 345 dogs (86%) had at least one problematic behavior. The main problematic behaviors reported for 345 dogs were excessive activity (38.7%), fearfulness (27.9%), destructiveness (27.2%), aggression toward unfamiliar people (23.7%) and roaming (22.4%). Small sized dogs were found to have higher fearfulness (P<0.001) and mounting and humping (P=0.005) than large sized ones. Fearfulness (P=0.008), withdrawal (P<0.001), aggression toward: unfamiliar people (P=0.003), dogs (P<0.001), and familiar people (P=0.01), respectively, and mounting and humping (P<0.001) were higher in the adult dogs than the puppies. Moreover, the female dogs were found to have higher fearfulness (P<0.001) and withdrawal (P=0.005) than the males. House soiling was significantly higher in dogs born in summer (P=0.005) and winter (P=0.008) than spring. Higher destructiveness (P=0.02) and house soiling (P<0.001) were found in dogs with a duration of ownership less than 6 months than those with more than 6 months. In the same vein, the outdoors dogs were found to have higher excessive activity (P<0.001) and aggression toward unfamiliar people (P=0.001) and dogs (P=0.005), whereas the higher fearfulness (P<0.001), withdrawal (P=0.02) and mounting and humping (P<0.001) were found in indoor dogs. Single dogs were found to have higher fearfulness (P=0.001) and mouthing and humping (P=0.004) than dogs from multi-dog homes. It is noteworthy that the higher mounting and humping was found more commonly in dogs owned by owners with academic degrees than those whose owners did not have any academic degrees (P=0.001). The findings proved the high prevalence of problematic behaviors in the studied companion dogs in the southwest of Iran. Veterinarians are expected to determine if there are any medical factors contributing to any behavior change in dogs, and decide whether their behavior change is typical, atypical, or pathological. However, dog owners should also be trained by veterinarians to know how to deal with problematic behaviors in dogs.
Article
Obsessive–compulsive disorder (OCD) is a relatively prevalent mental disorder that poses significant health burdens on the community. Although current conventional medications have good efficacy for many patients, they can elicit a range of associated adverse effects. Plant‐based compounds have been evaluated for different mental disorders, with a range of anxiolytic properties revealed. To determine the current evidence in the area, we conducted a systematic review using the electronic databases including PubMed, Scopus, and the Cochrane Library up to June 12, 2019, for pharmacological and clinical evidence of herbal medicines and phytochemicals with antiobsessive–compulsive effects. Additional search criteria were employed for locating research on the underpinning mechanisms of action. Results revealed that tentative low‐quality evidence exists for several plant medicines, including Crocus sativus, Silybum marianum, Echium amoenum, Hypericum perforatum, and Withania somnifera, along with several natural molecules, including crocin, cannabidiol, and curcumin. Although more research is needed to confirm effectiveness, present preclinical studies indicate that monoamine pathway modulation (in particular serotonin reuptake inhibition) may be the most important anti‐OCD mechanism among the studied natural compounds.